Demo Data from EDBT 2026 / reviewers in the wild / expert
Pallavi Surana
dblp:423/6167
· DBLP profile ↗
1ranked-venue papers
1as first author
1since 2021 · last 2024
0009-0004-4241-9181ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 first-author · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › gene expression analysis › gene expression pattern analysis
tissue-specific gene expression |
0.8 | 1 | 2024 | TransTEx: novel tissue-specificity scoring method for grouping human transcriptome into different expression groups · Bioinform. 2024 |
Bioinformatics and computational biology
transcriptomics |
0.8 | 1 | 2024 | TransTEx: novel tissue-specificity scoring method for grouping human transcriptome into different expression groups · Bioinform. 2024 |
Bioinformatics and computational biology › transcriptomics
alternative splicing analysis |
0.2 | 1 | 2024 | TransTEx: novel tissue-specificity scoring method for grouping human transcriptome into different expression groups · Bioinform. 2024 |
Methods — techniques the papers use, named apart from their topics
subsampling-based p-values · 0.8fold-change estimation · 0.8
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2024 | TransTEx: novel tissue-specificity scoring method for grouping human transcriptome into different expression groupsabstractMOTIVATION: Although human tissues carry out common molecular processes, gene expression patterns can distinguish different tissues. Traditional informatics methods, primarily at the gene level, overlook the complexity of alternative transcript variants and protein isoforms produced by most genes, changes in which are linked to disease prognosis and drug resistance. RESULTS: We developed TransTEx (Transcript-level Tissue Expression), a novel tissue-specificity scoring method, for grouping transcripts into four expression groups. TransTEx applies sequential cut-offs to tissue-wise transcript probability estimates, subsampling-based P-values and fold-change estimates. Application of TransTEx on GTEx mRNA-seq data divided 199 166 human transcripts into different groups as 17 999 tissue-specific (TSp), 7436 tissue-enhanced, 36 783 widely expressed (Wide), 79 191 lowly expressed (Low), and 57 757 no expression (Null) transcripts. Testis has the most (13 466) TSp isoforms followed by liver (890), brain (701), pituitary (435), and muscle (420). We found that the tissue specificity of alternative transcripts of a gene is predominantly influenced by alternate promoter usage. By overlapping brain-specific transcripts with the cell-type gene-markers in scBrainMap database, we found that 63% of the brain-specific transcripts were enriched in nonneuronal cell types, predominantly astrocytes followed by endothelial cells and oligodendrocytes. In addition, we found 61 brain cell-type marker genes encoding a total of 176 alternative transcripts as brain-specific and 22 alternative transcripts as testis-specific, highlighting the complex TSp and cell-type specific gene regulation and expression at isoform-level. TransTEx can be adopted to the analysis of bulk RNA-seq or scRNA-seq datasets to find tissue- and/or cell-type specific isoform-level gene markers. AVAILABILITY AND IMPLEMENTATION: TransTEx database: https://bmi.cewit.stonybrook.edu/transtexdb/ and the R package is available via GitHub: https://github.com/pallavisurana1/TransTEx. Pallavi Surana, Pratik Dutta, Ramana V. Davuluri |
Bioinform. | 1 |